Precision medicine for deadly brain cancer

June 14, 2021

Congratulations to iHealthtech Asst Prof Huilin Shao, and the scientists from the National Neuroscience Institute (NNI) and Duke NUS for winning a $9.88 million National Medical Research Council (NMRC) Open Fund – Large Collaborative Grant! This collaborative grant is aimed to find new diagnostic and treatment of #Glioblastoma (GBM), a type of deadly brain #tumour.

Dr Shao will be leading the research and development of a nanosensor platform to detect multiple tumour biomarkers and identify tumour subtypes via blood tests. The innovative technique will avoid invasive testing on brain tumours, obtain the tumour information accurately for proper therapy, and monitor drug treatment and disease progression.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

News